Overview

Cadonilimab in Combination With Ramucirumab for the Treatment of Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy

Status:
Recruiting

Trial end date:
2025-05-01

Target enrollment:

Participant gender:

Summary

To evaluate the efficacy Cadonilimab in combination with Ramucirumab for the treatment of advanced Hepatocellular Carcinoma that has failed at systemic therapy

Phase:

Phase 1

Details

Lead Sponsor:

Tianjin Medical University Cancer Institute and Hospital

Treatments:

Ramucirumab